The biotech company requested a trading halt before the market open on Friday. Here's why. The post Why are Mesoblast shares ...

As the new year sparks a wave of weight loss resolutions and millions turn to weight loss medications, rising costs and the growing popularity of compounded alternatives have raised critical questions ...

These amendments represent the first significant changes to “healthy” labeling requirements in 30 years. In its new scheme, the FDA attempts to bring labeling requirements in line with 21st century ...

Rule could make more medications available over the counter through a process called Additional Condition of Non-prescription Use (ACNU).

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Washington state tries new way to ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

A new study questioned the clinical utility of an algorithm meant to predict opioid use disorder (OUD) risk based on 15 ...

A new documentary premiering on Very Local is revealing the growing number of young men becoming more and more muscle-obsessed.

Trial confirms elinzanetant's efficacy and safety in addressing vasomotor symptoms caused by adjuvant endocrine therapy in ...

Stay updated on the latest potential FDA drug approvals in 2025, including an expanded label for Ozempic and new, nonopioid painkillers.

The Food and Drug Administration have seen a number of food items pulled from the shelves since the start of 2025, with the ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.50% and ...